Is 5mg Mounjaro enough to lose weight?

The myth: 5mg is a 'real' dose, so it should be working by now

This is the question our prescribers hear most often after someone has moved up from their first pen. The assumption is that 5mg represents a proper therapeutic threshold, that if significant weight loss hasn't arrived by now, something is wrong with the medicine or with you. Neither is true.

The 2.5mg starting dose exists to let your digestive system adjust to tirzepatide's effect on gastric emptying. Nausea and other gut-related side effects peak early and tend to fade as the body adapts. Moving to 5mg continues that adjustment process. You are still building tolerance at this stage. That doesn't mean nothing is happening metabolically, but it does mean that expecting dramatic results at 5mg misunderstands the design of the treatment.

The NHS patient information for tirzepatide describes this graduated schedule clearly: doses increase approximately every four weeks, guided by your prescriber, not by impatience. If you'd like more context on what the 2.5mg pen is designed to do before you reach this point, the page on whether 2.5mg Mounjaro is enough covers that in detail.

So the short answer is: 5mg is a meaningful step, but it is almost never the dose at which most people achieve their full weight-loss response.

What the trial data actually says about 5mg specifically

The SURMOUNT-1 trial (which followed 2,539 adults with obesity across 72 weeks) tested tirzepatide at 5mg, 10mg and 15mg against placebo. Average body-weight reduction at 5mg was around 15%, which is clinically significant. At 10mg the figure rose to around 19.5%, and at 15mg to roughly 20–21%. The dose-response relationship was real and meaningful.

What this tells you is that 5mg can produce weight loss, sometimes substantial weight loss, but that many people achieve considerably more at higher doses. The SURMOUNT programme (drawing on thousands of participants across its trials) consistently showed that tolerating and reaching a higher maintenance dose was associated with greater average outcomes. This doesn't mean 15mg is right for everyone; some people respond well at lower doses and their prescriber may choose to hold the titration there. Individual response is genuine, not a marketing caveat.

For a broader picture of how the full dose range is structured, our guide to what Mounjaro 5mg involves sets out what to expect during this specific step of treatment.

When staying at 5mg makes clinical sense, and when it doesn't

There are good reasons a prescriber might decide to keep you at 5mg for longer than the standard four-week window. If gastrointestinal side effects are still pronounced (persistent nausea, loose stools, reflux that hasn't settled) moving up before your body has adjusted is likely to make things worse, not better. The schedule is a guide; your comfort and safety come first.

Equally, if you are approaching a scheduled event (a holiday, a surgical procedure, a period of disrupted routine like Christmas or a change in work pattern) your prescriber may factor that in. Missing doses mid-titration is disruptive, and some people find a quiet domestic period better for adjusting to a new level. These are exactly the kinds of practical details worth raising in your aftercare consultations.

What is harder to justify, clinically, is staying at 5mg indefinitely without re-assessing. If tolerance is good and weight loss has stalled, the natural next step is a conversation with your prescriber about whether 7.5mg is appropriate. You can read more about that transition on the 7.5mg Mounjaro page. The full Mounjaro treatment overview also sets out how the licensed dose range is structured from start to maintenance.

How your prescriber decides whether to move your dose up

At nume, no dose increase happens without a clinical re-review. A prescriber looks at your current weight, your reported side-effect pattern, how long you've been at your current dose, and any relevant health changes since your last consultation. This is not a formality; it is the process that keeps you on the right track and catches anything that needs attention.

The NICE appraisal of tirzepatide (TA1026, published in December 2024) notes that treatment should be reviewed if weight loss is less than 5% after six months at the highest tolerated dose. That reference point applies to the full titration course, not to 5mg in isolation. It is a reason not to give up on the medicine prematurely, but also a reason to work through the dose schedule rather than stalling early.

If you are thinking about how private treatment is priced across the dose levels, the Mounjaro cost page gives honest context on how pricing works without reproducing per-pen figures in the body of this article. And if you want to understand what the clinical team at nume looks like before starting, our clinical lead's profile sets that out plainly.

If 5mg is where you currently are and you have questions about what comes next, the right place to start is a conversation with a prescriber. Check your eligibility for treatment with our clinical team and get a same-day review by a GPhC-registered prescriber.